What is TEGOPRAZAN used for?

TEGOPRAZAN is being studied to treat conditions like stomach ulcers, acid reflux (GERD), and infections caused by H. pylori.

How does TEGOPRAZAN work in the body?

TEGOPRAZAN works as a potassium-transporting ATPase blocker to help control acid production.

Is TEGOPRAZAN approved by the FDA?

No, TEGOPRAZAN is currently in Phase 3 clinical trials and is not yet an approved medication.

Can TEGOPRAZAN treat acid reflux?

Yes, TEGOPRAZAN is being investigated for the treatment of gastroesophageal reflux disease and laryngopharyngeal reflux.

Can TEGOPRAZAN help with stomach ulcers?

TEGOPRAZAN is being studied for its ability to treat both peptic ulcers and duodenal ulcers.

What is the current development stage of TEGOPRAZAN?

TEGOPRAZAN is currently in Phase 3 of clinical development.

tegoprazan | CAS 942195-55-3 | CLIQCDHNPDMGSL

Loading compound...

Potassium-transporting ATPase blocker

TEGOPRAZAN is a small molecule drug currently in late-stage clinical development (Phase 3). It works by blocking potassium-transporting ATPase, which helps manage acid-related conditions in the stomach and esophagus.

How it worksIt works by blocking an enzyme called potassium-transporting ATPase to manage acid levels.

Used for

Pepetic ulcersGastroesophageal reflux disease (GERD)Duodenal ulcersHelicobacter pylori infectionsLaryngopharyngeal reflux

Conditions

Pepetic ulcerGastroesophageal reflux diseaseDuodenal ulcerHelicobacter pylori infectious diseaseLaryngopharyngeal Reflux

Class

Potassium-transporting ATPase blockerGastrointestinal

How to take

TEGOPRAZAN is still in clinical trials and is not yet FDA-approved for general use.

Talk to your doctor

Questions to ask

·Is TEGOPRAZAAN right for my acid reflux?
·What are the potential risks of TEGOPRAZAAN?
·How does TEGOPRAZAAN differ from current acid blockers?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)